Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ISSAM I RAAD and ANNE-MARIE P CHAFTARI.
ISSAM I RAAD
Connection Strength
18.308
ANNE-MARIE P CHAFTARI
  1. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.
    View in: PubMed
    Score: 0.854
  2. A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac079.
    View in: PubMed
    Score: 0.824
  3. Advances in the prevention and management of central-line-associated bloodstream infections: The role of chelator-based catheter locks. Infect Control Hosp Epidemiol. 2019 09; 40(9):1036-1045.
    View in: PubMed
    Score: 0.686
  4. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients. Infect Control Hosp Epidemiol. 2018 06; 39(6):727-729.
    View in: PubMed
    Score: 0.637
  5. Unnecessary Removal of Central Venous Catheters in Cancer Patients with Bloodstream Infections. Infect Control Hosp Epidemiol. 2018 02; 39(2):222-225.
    View in: PubMed
    Score: 0.620
  6. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother. 2017 08; 61(8).
    View in: PubMed
    Score: 0.600
  7. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.597
  8. A clinical practical approach to the surveillance definition of central line-associated bloodstream infection in cancer patients with mucosal barrier injury. Am J Infect Control. 2016 08 01; 44(8):931-4.
    View in: PubMed
    Score: 0.550
  9. Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer. Antimicrob Agents Chemother. 2016 01; 60(1):239-44.
    View in: PubMed
    Score: 0.531
  10. Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection. PLoS One. 2015; 10(7):e0130999.
    View in: PubMed
    Score: 0.521
  11. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S340-3.
    View in: PubMed
    Score: 0.498
  12. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections. BMC Infect Dis. 2014 Sep 24; 14:518.
    View in: PubMed
    Score: 0.493
  13. Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation. Transplantation. 2012 Aug 15; 94(3):302-8.
    View in: PubMed
    Score: 0.426
  14. The prevention of biofilm colonization by multidrug-resistant pathogens that cause ventilator-associated pneumonia with antimicrobial-coated endotracheal tubes. Biomaterials. 2011 Apr; 32(11):2689-94.
    View in: PubMed
    Score: 0.383
  15. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. 2011 Jun 01; 117(11):2551-8.
    View in: PubMed
    Score: 0.380
  16. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
    View in: PubMed
    Score: 0.364
  17. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers (Basel). 2024 Oct 11; 16(20).
    View in: PubMed
    Score: 0.247
  18. In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC Antimicrob Resist. 2024 Apr; 6(2):dlae060.
    View in: PubMed
    Score: 0.239
  19. Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients. Cancers (Basel). 2024 Mar 05; 16(5).
    View in: PubMed
    Score: 0.237
  20. In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC Antimicrob Resist. 2023 Dec; 5(6):dlad132.
    View in: PubMed
    Score: 0.234
  21. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023 02 07; 12.
    View in: PubMed
    Score: 0.220
  22. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.220
  23. Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19. Elife. 2022 12 21; 11.
    View in: PubMed
    Score: 0.218
  24. Prevention of device-related infections in patients with cancer: Current practice and future horizons. CA Cancer J Clin. 2023 03; 73(2):147-163.
    View in: PubMed
    Score: 0.215
  25. Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant. J Fungi (Basel). 2022 Jan 13; 8(1).
    View in: PubMed
    Score: 0.205
  26. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.
    View in: PubMed
    Score: 0.202
  27. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score. Cancer Med. 2021 12; 10(23):8475-8482.
    View in: PubMed
    Score: 0.202
  28. Management of enterococcal central line-associated bloodstream infections in patients with cancer. BMC Infect Dis. 2021 Jul 05; 21(1):643.
    View in: PubMed
    Score: 0.197
  29. Novel antimicrobial ointment for infected wound healing in an in vitro and in vivo porcine model. Wound Repair Regen. 2021 09; 29(5):830-842.
    View in: PubMed
    Score: 0.195
  30. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors? J Med Virol. 2021 Jul; 93(7):4083-4084.
    View in: PubMed
    Score: 0.193
  31. Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs). Biomed Res Int. 2019; 2019:2869039.
    View in: PubMed
    Score: 0.177
  32. Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia. Open Forum Infect Dis. 2019 Oct; 6(10):ofz357.
    View in: PubMed
    Score: 0.175
  33. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).
    View in: PubMed
    Score: 0.171
  34. Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Meta-Analysis. JPEN J Parenter Enteral Nutr. 2019 09; 43(7):832-851.
    View in: PubMed
    Score: 0.171
  35. Corrigendum to "Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia?" [Diagn Microbiol Infect Dis 2019;76(2):158-161]. Diagn Microbiol Infect Dis. 2019 05; 94(1):105.
    View in: PubMed
    Score: 0.168
  36. International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients. Mediterr J Hematol Infect Dis. 2019; 11(1):e2019003.
    View in: PubMed
    Score: 0.166
  37. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis. 2018 Dec 13; 18(1):656.
    View in: PubMed
    Score: 0.165
  38. Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy. Open Forum Infect Dis. 2018 Oct; 5(10):ofy249.
    View in: PubMed
    Score: 0.163
  39. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World J Hepatol. 2018 Sep 27; 10(9):549-557.
    View in: PubMed
    Score: 0.163
  40. Biomarkers of Sepsis and Bloodstream Infections: The Role of Procalcitonin and Proadrenomedullin With Emphasis in Patients With Cancer. Clin Infect Dis. 2018 08 31; 67(6):971-977.
    View in: PubMed
    Score: 0.162
  41. Emerging outbreaks associated with conflict and failing healthcare systems in the Middle East. Infect Control Hosp Epidemiol. 2018 10; 39(10):1230-1236.
    View in: PubMed
    Score: 0.161
  42. Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients. Mediterr J Hematol Infect Dis. 2018; 10(1):e2018028.
    View in: PubMed
    Score: 0.158
  43. Author Correction: Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 Apr 19; 8(1):6258.
    View in: PubMed
    Score: 0.158
  44. Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia. Sci Rep. 2018 01 18; 8(1):1099.
    View in: PubMed
    Score: 0.155
  45. Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm. Front Microbiol. 2017; 8:1999.
    View in: PubMed
    Score: 0.153
  46. Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. Int J Antimicrob Agents. 2017 Sep; 50(3):384-388.
    View in: PubMed
    Score: 0.150
  47. In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections. Antimicrob Agents Chemother. 2017 06; 61(6).
    View in: PubMed
    Score: 0.148
  48. Novel plasma telomerase detection method to improve cancer diagnostic assessment. PLoS One. 2017; 12(5):e0174266.
    View in: PubMed
    Score: 0.148
  49. Comparing catheter-related bloodstream infections in pediatric and adult cancer patients. Pediatr Blood Cancer. 2017 Oct; 64(10).
    View in: PubMed
    Score: 0.147
  50. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Antimicrob Agents Chemother. 2017 04; 61(4).
    View in: PubMed
    Score: 0.147
  51. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control. 2017 Mar 01; 45(3):e34-e39.
    View in: PubMed
    Score: 0.146
  52. Comparative Efficacies of Antimicrobial Catheter Lock Solutions for Fungal Biofilm Eradication in an in Vitro Model of Catheter-Related Fungemia. J Fungi (Basel). 2017 Feb 10; 3(1).
    View in: PubMed
    Score: 0.145
  53. Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis. 2016 Nov; 16(11):e241-e250.
    View in: PubMed
    Score: 0.143
  54. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother. 2016 09; 60(9):5175-81.
    View in: PubMed
    Score: 0.141
  55. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother. 2016 06; 60(6):3426-32.
    View in: PubMed
    Score: 0.138
  56. Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal Organism. Medicine (Baltimore). 2016 Apr; 95(14):e2691.
    View in: PubMed
    Score: 0.137
  57. The influence of using antibiotic-coated peripherally inserted central catheters on decreasing the risk of central line-associated bloodstream infections. Am J Infect Control. 2016 09 01; 44(9):1037-40.
    View in: PubMed
    Score: 0.136
  58. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med. 2014 Dec; 42(12):2500-7.
    View in: PubMed
    Score: 0.125
  59. Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer. Am J Infect Control. 2014 Oct; 42(10):1127-9.
    View in: PubMed
    Score: 0.124
  60. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother. 2014 Nov; 69(11):3148-55.
    View in: PubMed
    Score: 0.122
  61. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters. Antimicrob Agents Chemother. 2014 Sep; 58(9):5291-6.
    View in: PubMed
    Score: 0.121
  62. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. 2014 May; 46(3):163-8.
    View in: PubMed
    Score: 0.118
  63. Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother. 2014; 58(2):1179-82.
    View in: PubMed
    Score: 0.116
  64. Can procalcitonin differentiate Staphylococcus aureus from coagulase-negative staphylococci in clustered gram-positive bacteremia? Diagn Microbiol Infect Dis. 2013 06; 76(2):158-61.
    View in: PubMed
    Score: 0.111
  65. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol. 2013 Jul; 24(7):1873-1879.
    View in: PubMed
    Score: 0.111
  66. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis. 2013 Apr; 56(7):943-50.
    View in: PubMed
    Score: 0.109
  67. Management of rapidly growing mycobacterial bacteremia in cancer patients. Clin Infect Dis. 2013 Mar; 56(6):843-6.
    View in: PubMed
    Score: 0.109
  68. Nephrostomy tube related pyelonephritis in patients with cancer: epidemiology, infection rate and risk factors. J Urol. 2013 Jan; 189(1):130-5.
    View in: PubMed
    Score: 0.108
  69. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer. 2012 Dec 01; 118(23):5823-9.
    View in: PubMed
    Score: 0.105
  70. Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One. 2012; 7(3):e32945.
    View in: PubMed
    Score: 0.103
  71. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 2012 Feb; 56(2):935-41.
    View in: PubMed
    Score: 0.101
  72. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis. 2011 Sep; 17(9):1651-8.
    View in: PubMed
    Score: 0.100
  73. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51.
    View in: PubMed
    Score: 0.096
  74. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009 Oct 15; 49(8):1187-94.
    View in: PubMed
    Score: 0.088
  75. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore). 2009 Sep; 88(5):279-283.
    View in: PubMed
    Score: 0.087
  76. Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel). 2021 Aug 13; 13(16).
    View in: PubMed
    Score: 0.050
  77. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes. Ann Med. 2018 12; 50(8):713-720.
    View in: PubMed
    Score: 0.041
  78. Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial. JAMA. 2018 09 25; 320(12):1249-1258.
    View in: PubMed
    Score: 0.041
  79. International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections. Expert Rev Med Devices. 2018 Jun; 15(6):461-466.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.